Table 1.
Epidemiological characteristics of the cohorts
| Group | N | Gender | Age (years) | |||
|---|---|---|---|---|---|---|
| Male | Female | Range | Mean | SEM | ||
| NM-LRRK2G2019S | 6 | 3 (50%) | 3 (50%) | 34–61 | 46.67 | 4.04 |
| PD-LRRK2G2019S | 7 | 3 (42.85%) | 4 (57.15%) | 44–71 | 60.57 | 3.15 |
| Control | 8 | 3 (37.50%) | 5 (62.50%) | 41–69 | 56.00 | 3.63 |
Epidemiological data of the studied cohorts at the time of skin biopsy. No significant differences were found in age or gender between groups
NM-LRRK2G2019S: Non-manifesting LRRK2G2019S-mutation carriers; PD-LRRK2G2019S: patients with LRRK2G2019S-mutation and clinically manifest PD; N: Number of cases enrolled; SEM: Standard error of the mean